Acute rapamycin nephrotoxicity in native kidneys of patients with chronic glomerulopathies.

Autor: Fervenza, Fernando C, Fitzpatrick, Peter M, Mertz, Jim, Erickson, Stephen B, Liggett, Scott, Popham, Sandy, Wochos, Daniel N, Synhavsky, Arkady, Hippler, Steven, Larson, Timothy S, Bagniewski, Stephanie M, Velosa, Jorge A
Zdroj: Nephrology Dialysis Transplantation; May 2004, Vol. 19 Issue: 5 p1288-1292, 5p
Abstrakt: Based on its success as a transplant immunosuppressor, there is intense interest in using rapamycin in the treatment of progressive glomerulopathies involving native kidneys. However, we call attention to the potential toxicity associated with the use of rapamycin in this setting.
Databáze: Supplemental Index